L-ASPARAGINASE-INDUCED DIABETIC KETOACIDOSIS IN AN ADULT WITH ACUTE LYMPHOBOLASTIC LEUKEMIA
Keywords:
diabetic ketoacidosis, l-asparanginase, acute lymphobolastic, leukemiaAbstract
INTRODUCTION
The mainstay treatment for acute lymphoblastic leukemia (ALL) includes L-asparaginase, doxorubicin, vincristine, and prednisone. Hyperglycemia is common with asparaginase, with or without glucocorticoid therapy. Development of diabetic ketoacidosis (DKA) however, is rare and mostly reported in children with an incidence of 0.8%. Incidence among adults is unknown. Fourteen cases have been reported in patients below 18 years old, and only 3 occurring in 21 to 25-year-olds. This case is of a 57-yearold female with precursor B cell ALL developing DKA post 3rd cycle of L-asparaginase therapy.
CASE
Literature reviewed from 1986 to present revealed seventeen cases of DKA post L-asparaginase therapy.
CONCLUSION
This report shows that DKA from L-asparaginase occurs even in the older population. It is vital that patients with hyperglycemia and decreased sensorium receiving L-asparaginase for ALL be screened for DKA. Determination of risk factors among patients who develop DKA from L-asparaginase is important in order to prevent future incidences.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.